Clinical Trial Update: Rivaroxaban for Scheduled Work-up of DVT - The Ri-Schedule Study [Phase 3]

View source ↗

Summary

Phase 3 Ri-Schedule trial evaluating rivaroxaban for scheduled work-up of deep vein thrombosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Ostfold Hospital Trust | Conditions: Deep Venous Thrombosis | Phase 3 | Status: COMPLETED